Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Antioxidants could help Huntington’s Disease sufferers

Therapeutic strategies to strengthen antioxidant defences could help to prevent the progression of Huntington’s Disease. This is the suggestion from the results of the first ever trial on human samples carried out by researchers at the University of Lleida. The results have been published in the latest issue of Free Radical Biology & Medicine magazine.

A study carried out by Catalan researchers shows that oxidative stress and damage to certain macromolecules are involved in the progression of Huntington’s Disease (HD), which is characterised by psychiatric and cognitive disturbance, involuntary movements (chorea) and dementia.

The research was carried out using human brain samples obtained post mortem from people affected by HD, which were compared with samples from control patients (C) who had died from unrelated illnesses or other causes. The two cerebral areas most affected by this illness – the striate cortex and cortex – were studied.

The samples, which were provided by the tissue bank at the University of Barcelona’s Institute of Neuropathology, were divided into HD-C group pairs based on gender, age, and the length of time after death before the tissue had been removed.

“Bidimensional electrophoresis techniques were used to compare the differences between the proteins present in the brains of the sick people and those of the controls,” said Elisa Cabiscol, professor of biochemistry at the University of Lleida, and one of the report’s authors. “The results showed that more than half of these were enzymes related to antioxidant defence systems.”

This study, which used human samples for the first time and was funded by Spain’s Consolider-Ingenio 2010 Programme, found that the brain tissue from people suffering from HD had elevated levels of proteins that eliminate reactive oxygen species (ROS), or free radicals, as they are more commonly known.

“There is a situation we call oxidative stress in the brains of these patients, and as a result the neurones (and other cells in the brain, such as the glia cells) attempt to defend themselves by increasing their antioxidant defences,” said Cabiscol.

In normal conditions, the balance between ROS generation and antioxidant systems allows cells to function correctly. However, in a situation of oxidative stress, ROS generation exceeds the cells’ defence capacity, causing changes in the cells that ultimately cause them to die.

“Our proteomic study has made clear how important a role oxidative stress plays in this illness, calling for the use of therapeutic strategies that boost antioxidant defences or prevent the formation of ROS, on order to try to halt or slow down the progression of this devastating disease,” added the researcher.

Huntington’s Disease

HD is caused by degeneration of cells in the brain, the neurones, as a result of genetic changes. The symptoms of this disease that runs in families first become apparent in middle age, and it progresses over 15 to 20 years before leading to an inevitable death. Both the speed at which the disease progresses and the age of onset varies from one person to another.

Mutation on the /htt/ gene generates an abnormal protein (huntingtin), which has a ‘polyglutamine tail’. These polyglutamines eventually cause the protein to form aggregates. “What we still don’t understand is the function of this protein, and how the presence of these aggregates causes the neurones in certain areas of the brain to malfunction and die,” said Cabiscol.

Statistical estimates show that one in every 10,000 people suffers from HD, translating into more than 4,000 sufferers in a country such as Spain. However, Montse Torrecilla, secretary of the Spanish Huntington’s Chorea Association (ACHE), says there is a lack of real data on the number of patients. “This is a complex issue, because one has to bear in mind the number of misdiagnoses and people who hide, or are still not aware of, their illness,” she said.

SINC Team | alfa
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>